10.1038/s41386-019-0531-4 Summary Keywords addiction, dependence, reward, dopamine, gutbrain axis, appetite regulation Citation Jerlhag E (2023) The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
The composite primary endpoint was the difference in 90-day mortality or LT, which the trial did not meet
Werner ER, Blau N, Thny B
A., Dragani, L., Valente, R., Di Lisa, F., Saggin, R., & Vecchiet, L
Referral to hepatology is recommended for patients with: Elevated fibrosis risk on FIB-4 or ELF testing (per NICE NG49) Signs of decompensation : jaundice, ascites (abdominal swelling), hepatic encephalopathy (confusion), or gastrointestinal bleeding Uncertain diagnosis or complex management needs Nutritional support from a dietitian experienced in liver disease can optimise outcomes